Elmira Vagapova

2PUBLICATIONS
2CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 04, 2024
Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis?

Elmira Khabusheva, Margaret A Goodell

|Sep 24, 2021
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes.

Timofey Lebedev, Elmira Vagapova, Pavel Spirin

Pageof 1